Labour Leadership Candidate Wes Streeting Proposes Reforms to Capital Gains Tax in Wealth Tax That Works Pledge SP 500 Ekes Out Gains as Healthcare and Technology Lead Communication Services Lags Feds Tightening Dilemma Strong Jobs Data Undermines Case for Rate Cuts Infrastructure Control as the Next Frontier for Financial Returns AI Talent Arms Race Tech Giants Pay Millions in Salaries Billions in Equity to Secure Top Researchers TMCI Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Rally EBC Q1 2026 Earnings EPS Misses Estimates Shares Unchanged ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue CUBE Q1 2026 Earnings EPS Edges Past Estimates Amid Steady SelfStorage Demand RDHL Q2 2022 Earnings Massive EPS Miss Despite No Revenue Stock Rises 481 ONFOW Warrants Edge Higher in Thin Trading Potential Support at 006 Holds KalVista Pharmaceuticals KALV Holds Steady Near Support as Biotech Sector Watches for Catalyst Pathward Financial CASH Edges Lower as Resistance Holds Near 8650 SBA Communications SBAC Holds Near 202 Trapped Between Key Technical Levels OneSpan Inc OSPN Edges Higher Amid Modest Trading Activity OneStream OS Stock Holds Steady at 24 Testing Key Support and Resistance Levels SK Hynix Achieves Record Profit Fueled by AI Chip Demand SN Q1 2026 Earnings EPS Beat Powered by Operational Efficiency BMW Explores Humanoid Robots in European Car Plant Building on US Initiatives SP 500 MeltUp Scenario Could the Index Reach 8000 or Higher GTIM Q1 2026 Earnings Positive EPS Amidst Limited Disclosures TAL Education Group Edges Higher Amid Sector Stabilization TAL Stock Analysis PSNY Q4 2024 Earnings Massive EPS Miss Despite Stock Rally FGN Q1 2026 Earnings EPS Misses Estimates as Net Income Falls Short PONY Q1 2026 Earnings NarrowerThanExpected Loss as Autonomous Driving Firm Shows Cost Discipline MBWM Q1 2026 Earnings Earnings Beat Expectations on Strong Net Interest Margin PAVmed Q1 2026 Earnings Deeply Negative EPS Surprise Amid Operational Challenges ENVB Q4 2024 Earnings Significant EPS Miss as Company Continues Clinical Development Without Revenue WU Q1 2026 Earnings EPS Falls Short of Estimates Despite Minor Stock Uptick